Effect of Basti therapy of Ayurveda in chronic kidney disease treatment
- Conditions
- Health Condition 1: N184- Chronic kidney disease, stage 4 (severe)
- Registration Number
- CTRI/2024/02/062819
- Lead Sponsor
- All India Institute of Ayurveda, New Delhi
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
1. Patients of both genders having age group 21-65 yrs. with confirmed diagnosis of stage up to G4 as per standard KDIGO-CRITERIA, not having undergone RRT were included.
2. Patients under controlled Diabetes and Hypertension with or without conventional medications.
1. Patients suffering from Tuberculosis, Malignancy, Pregnancy and lactation, or any other systemic illness.
2. Uncontrolled diabetes and HTN
3. HIV-associated nephropathy and transplant allograph failure
4. Renal Artery stenosis.
5. Neoplasm of Kidney.
6. History of previous kidney transplant.
7. Patients of Congenital Renal Diseases like Autosomal dominant and Recessive Polycystic Kidney disease, Congenital Nephrotic syndrome, Alports syndrome, Fabrys disease and juvenile Nephronophthisis.
8. Patients with other added complications
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Reduction in values of KFT about 30% from baseline (Sr Creatinine, Blood urea, <br/ ><br>Serum Uric acid level)Timepoint: Day 0, 15, 30, 45, 60 and 120 day of Follow up
- Secondary Outcome Measures
Name Time Method Improvement in quality of lifeTimepoint: Day 0, 30, 60 and 120 day of Follow up